Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1或PD-L1阻断疗法无效的转移性黑色素瘤:一项随机II期试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-023-02498-y
VanderWalde, Ari; Bellasea, Shay L; Kendra, Kari L; Khushalani, Nikhil I; Campbell, Katie M; Scumpia, Philip O; Kuklinski, Lawrence F; Collichio, Frances; Sosman, Jeffrey A; Ikeguchi, Alexandra; Victor, Adrienne I; Truong, Thach-Giao; Chmielowski, Bartosz; Portnoy, David C; Chen, Yuanbin; Margolin, Kim; Bane, Charles; Dasanu, Constantin A; Johnson, Douglas B; Eroglu, Zeynep; Chandra, Sunandana; Medina, Egmidio; Gonzalez, Cynthia R; Baselga-Carretero, Ignacio; Vega-Crespo, Agustin; Garcilazo, Ivan Perez; Sharon, Elad; Hu-Lieskovan, Siwen; Patel, Sapna P; Grossmann, Kenneth F; Moon, James; Wu, Michael C; Ribas, Antoni